Selectin Inhibitors and Their Proposed Role in Ischemia and Reperfusion

REFERENCES

• Kogan T P, Dupré B, Bui H, McAbee K L, Kassir J M, Scott I L, Hu X, Vanderslice P, Beck P J, Dixon R AF. Novel synthetic inhibitors of selectin-mediated cell adhesion: Synthesis of 1,6-bis [3-(3-carboxymethylphenyl)-4-(2-α -D-mannopyranosyloxy)phenyl] hexane (TBC1269). J Med Chem. 1998; 41: 1099–1111
   PubMed Web of Science ®Google Scholar
• Davenpeck K L, Berens K L, Dixon R AF, Dupré B, Bochner B S. Inhibition of adhesion of human neutrophils and esoinophils to P-selectin by the sialyl Lewisx antagonist TBC1269: Preferential activity against neutrophil adhesion in vitro. J Allergy Clin Immunol. 2000; 105: 769–775
   PubMed Web of Science ®Google Scholar
• Harlan J M, Liu D Y. Adhesion: Its Role in Inflammatory Disease. WH Freeman, New York 1992; 19–43
   Google Scholar
• Ley K. The role of selectins in inflammation and disease. Trends Mol Med 2003; 9: 263–268
   PubMed Web of Science ®Google Scholar
• Lefer D J. Pharmacology of selectin inhibitors in ischemia/reperfusion states. Annu Rev Pharmacol Toxicol. 2000; 40: 283–294
   PubMed Web of Science ®Google Scholar
• Martinez-Mier G, Toledo-Pereyra L H, Ward P A. Adhesion molecules and hemorrhagic shock. J Trauma. 2001; 51: 408–415
   PubMedGoogle Scholar
• Kaila N, Thomas B E. IV. Design and synthesis of sialyl Lewisx mimics as E- and P-selectin inhibitors. Med Res Rev. 2002; 22: 566–601
   PubMed Web of Science ®Google Scholar
• Lutters B CH, Leeuwenburgh M A, Appeldoorn C CM, Molenaar T JM, Van Berkel T JC, Biessen E AL. Blocking endothelial adhesion molecules: A potential therapeutic strategy to combat atherogenesis. Curr Opin Lipidol 2004; 15: 545–552
   PubMed Web of Science ®Google Scholar
• Boehncke W H, Schön M P. Interfering with leukocyte rolling—A promising therapeutic approach in inflammatory skin disorders. Trends Pharm Sci. 2003; 24: 49–52
   PubMed Web of Science ®Google Scholar
• Toledo-Pereyra L H, Toledo A H, Walsh J, Lopez-Neblina F. Molecular signaling pathways in ischemia/reperfusion. Exp Clin Transpl. 2004; 2: 174–177
   PubMedGoogle Scholar
• Winn R K, Paulson J C, Harlan J M. A monoclonal antibody to P-selectin ameliorates injury associated with hemorrhagic shock in rabbits. Am J Physiol. 1994; 267: H2391–2397, (Pt2)
   PubMedGoogle Scholar
• Lefer A M, Campbell B, Shin Y-K. Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion. J Mol Cell Cardiol. 1998; 30: 2561–2566
   PubMed Web of Science ®Google Scholar
• Dulkanchainun T S, Goss J A, Imagawa D K, Shaw G D, Anselmo D M, Kaldas F, Wang T, Zhao D, Busuttil A A, Kato H, Murray N GB, Kupiec-Weglinski J W, Busuttil R W. Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg. 1998; 227: 832–840
   PubMed Web of Science ®Google Scholar
• Hayward R, Campbell B, Shin Y K, Scalia R, Lefer A M. Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Card Res. 1998; 41: 65–76
   Web of Science ®Google Scholar
• http://www.ysthera.com
   Google Scholar
• Slee D H, Romano J Y, Nguyen T N, John J K, Raheja N K, Axe F U, Jones T K, Ripka W C. Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with anitiinflammatory activity. J Med Chem. 2001; 44: 2094–2107
   PubMed Web of Science ®Google Scholar
• http://www.revotar.com
   Google Scholar
• Hicks A ER, Abbitt K B, Dodd P, Ridger V C, Hellewell P G, Norman K E. The anti-inflammatory effects of a selectin ligand mimetic, TBC-1269, are not a result of competitive inhibition of leukocyte rolling in vivo. J Leukocyte Biol 2005; 77: 59–66
   PubMed Web of Science ®Google Scholar
• Ramos-Kelly J R, Toledo-Pereyra L H, Jordan J A, Rivera-Chavez F A, Dixon R AF, Ward P A. Upregulation of lung chemokines associated with hemorrhage is reversed with a small molecule multiple selectin inhibitor. J Am Coll Surg. 1999; 189: 546–553
   PubMed Web of Science ®Google Scholar
• Nemoto T, Burne M J, Daniels F, O'Donnell M P, Crosson J, Berens K, Issekutz A, Kasiske B L, Keane W F, Raab H. Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int. 2001; 60: 2205–2214
   PubMed Web of Science ®Google Scholar
• Palma-Vargas J M, Toledo-Pereyra L H, Dean R E, Harkema J M, Dixon R AF, Kogan T P. Small-molecule selectin inhibitor protects against liver inflammatory response after ischemia and reperfusion. Am Coll Surgeons. 1997; 185: 379–387
   Web of Science ®Google Scholar
• Martinez-Mier G, Toledo-Pereyra L H, Ward P A. Adhesion molecules in liver ischemia and reperfusion. J Surg Res. 2000; 94: 185–194
   PubMed Web of Science ®Google Scholar
• Toledo-Pereyra L H, Lopez-Neblina F, Reuben J S, Toledo A H, Ward P A. Selectin inhibition modulates Akt/MAPK signaling and chemokine expression after liver ischemia–reperfusion. J Invest Sur. 2004; 17: 303–313
   PubMed Web of Science ®Google Scholar
• Ramos-Kelly J R, Toledo-Pereyra L H, Jordan J, Rivera-Chavez F, Rohs T, Holevar M, Dixon R AF, Yun E, Ward P A. Multiple selectin blockade with a small molecule inhibitor downregulates liver chemokine expression and neutrophil infiltration after hemorrhagic shock. J Trauma 2000; 49: 92–100
   PubMedGoogle Scholar
• Langer R, Wang M, Stepkowski S M, Hancock W W, Han R, Li P, Feng L, Kirken R A, Berens K L, Dupré B, Podder H, Dixon R AF, Kahan B D. Selectin inhibitor Bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines. J Am Soc Nephrol. 2004; 15: 2893–2901
   PubMed Web of Science ®Google Scholar
• Jayle C, Milinkevitch S, Favreau F, Doucet C, Richer J P, Deretz S, Mauco G, Raab H, Hauet T. Protective role of selectin ligand inhibition in a large animal model of kidney ischemia–reperfusion injury. Kidney Int. 2006; 69: 1749–1755
   PubMed Web of Science ®Google Scholar
• Onai Y, Suzuki J, Nishiwaki Y, Gotoh R, Berens K, Dixon R, Yoshida M, Ito H, Isobe M. Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischemia/reperfusion injury. Eur J Pharmacol. 2003; 481: 217–225
   PubMed Web of Science ®Google Scholar
• Ulbrich H, Eriksson E E, Lindbom L. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharm Sci. 2003; 24: 640–647
   PubMed Web of Science ®Google Scholar
• Romano S J. Selectin antagonists. Treat Respir Med. 2005; 4: 85–90
   PubMedGoogle Scholar
• Toledo-Pereyra L H, Lopez-Neblina F, Lentsch A B, Anaya-Prado R, Romano S J, Ward P A. Selectin inhibition modulates NF-κ B and AP-1 signaling after liver ischemia/reperfusion. J Invest Surg. 2006; 19: 313–322
   PubMed Web of Science ®Google Scholar
• Schön M P, Krahn T, Schön M, Rodriguez M-L, Antonicek H, Schultz J E, Ludwig R J, Zollner T M, Bischoff E, Bremm K-D, Schramm M, Henninger K, Kaufmann R, Gollnick H PM, Parker C M, Boehncke W-H. Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat Med. 2002; 8: 366–372
   PubMed Web of Science ®Google Scholar
• Wienrich B G, Krahn T, Schön M, Rodriguez M L, Kramer B, Busemann M, Boehncke W H, Schön M P. Structure–function relation of efomycines, a family of small-molecule inhibitors of selectin functions. J Invest Dermatol 2006; 126: 882–889
   PubMed Web of Science ®Google Scholar
• Kaila N, Somers W S, Thomas B E, Thakker P, Janz K, DeBernardo S, Tam S, Moore W J, Yang R, Wrona W, Bedard P W, Crommie D, Keith J C, Tsao D HH, Alvarez J C, Ni H, Marchese E, Patton J T, Magnani J L, Camphausen R T. Quinic acid derivatives as sialyl Lewisx-mimicking selectin inhibitors: Design, synthesis, and crystal structure in complex with E-selectin. J Med Chem. 2005; 48: 4346–4357
   PubMed Web of Science ®Google Scholar
• Shima H, Tsuruma T, Sahara H, Takenouchi M, Takahashi N, Iwayama Y, Yagihashi A, Watanabe N, Sato N, Hirata K. Treatment with β -SQAG9 prevents rat hepatic ischemia–reperfusion injury. Transpl Proc. 2005; 37: 417–421
   PubMed Web of Science ®Google Scholar
• Cahmoun F, Burne M, O'Donnell M, Rabb H. Pathophysiologic role of seletins and their ligands in ischemia reperfusion injury. Front Biosci. 2000; 5: e103–e109
   Google Scholar